Concepedia

Amy M. Avila

AM

Statistics

Publications

2

Citations

228

H-Index

2

Active since

2020

Affiliations

United States Food and Drug Administration(Current)

National Center for Toxicological Research

Center for Drug Evaluation and Research

Amy M. Avila is an author at United States Food and Drug Administration specializing in preclinical safety evaluation, nonclinical study design, and pharmacy.

Publications per year

2020–2023

2

Publications

2

An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs)

Amy M. Avila, Ilona Bebenek, Jessica A. Bonzo et al. · Regulatory Toxicology and Pharmacology · 2020 · 183 citations

, , +14

Gaps and challenges in nonclinical assessments of pharmaceuticals: An FDA/CDER perspective on considerations for development of new approach methodologies

Amy M. Avila, Ilona Bebenek, Donna L. Mendrick et al. · Regulatory Toxicology and Pharmacology · 2023 · 45 citations

, , +11

1–2 of 2